Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : WR, LB and Friends. NO HYPESTERS OR SCAMMERS -- Ignore unavailable to you. Want to Upgrade?

To: Kimberly Lee who wrote (6885)	4/11/1999 5:43:00 PM
From: MasterConfucius	Read Replies (1) \| Respond to of 13776

EYPI is a sleeper stock that I feel has a lot of potential in 1999 and beyond. I don't normally suggest picks, but I thought I'd bring it to the attention of this thread. The company basically markets "anti-aging" vitamin pills through TV infomercials produced by Guthy-Renker, the same company that succesfully markets Tony Robbins and Victoria Principal's products. This allows EYPI to air its infomercials in over 100 major TV markets on CNBC, Lifetime, Bravo, and a host of other channels. The result has been impressive sales for the first quarter of over 3.4M (1.4M in February, and 1.7M in March). The shares outstanding is only 2.9M, so EYPI's sales have reached 1.00 a share in just two months since their infomercials began to air in January. They've received over 350,000 hits on their web site and have signed up almost 50,000 customers (many should be return customers) They plan to start internet sales soon, and they already have orders set up at on of Guthy-Renker's internet sites www.buyontheweb.com under nutrition. The only potential drawback to this stock is that nutraceuticals, foods that are supposed to enhance lifestyles and health, are somewhat controversial. Nevertheless, it is lucrative. Frost & Sullivan (www.frost.com) examined the Nutraceuticals and Functional Foods Markets, and the total market was estimated to be $4.5 billion in 1998, and it is continuing to grow rapidly as more people are becoming willing to experiement with alternative medicines, traditional herbal remedies and nutritional supplements. This isn't a good daytrading stock as it has witnessed extremely low volume. Nobody seems willing to sell, but there aren't alot of buyers either. This is something to keep an eye on, as I believe that the company will continue to report substantial sales. They plan to become fully reporting with the SEC in the spring of 1999, and are currently profitable. I started a new thread on EYPI, so anybody interested in this company can join me over there.